Offer - Urjas Oil for just ₹ 1 X
Rispond 1 Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Schizophrenia. Rispond 1 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Rispond 1 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Rispond 1 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Rispond 1 Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Rispond 1 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. In addition, Rispond 1 Tablet's effects on the liver, heart and kidney are discussed below in the Rispond 1 Tablet related warnings section.
Rispond 1 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Tardive Dyskinesia, Kidney Disease, Liver Disease are examples of such conditions. Some other conditions that can be affected by Rispond 1 Tablet are listed in the contraindications section below.
Besides this, Rispond 1 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to the above precautions for Rispond 1 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Rispond 1 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Rispond 1 Tablet safe for pregnant women?
Rispond may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Rispond again without your doctor's advice.
Is the use of Rispond 1 Tablet safe during breastfeeding?
Taking Rispond may lead to serious side effects if you are breastfeeding. Rispond should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Rispond 1 Tablet on the Kidneys?
Rispond has very mild side effects on the kidneys.
What is the effect of Rispond 1 Tablet on the Liver?
Side effects of Rispond rarely affect the liver.
What is the effect of Rispond 1 Tablet on the Heart?
Rispond is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Rispond 1 Tablet unless your doctor advises you to do so -
Is this Rispond 1 Tablet habit forming or addictive?
No, there is no any evidence that Rispond 1 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Rispond 1 Tablet can make you feel drowsy.
Is it safe?
Yes, but take Rispond 1 Tablet only as per medical advice.
Is it able to treat mental disorders?
Yes, Rispond 1 Tablet is useful in treating mental disorders.
Interaction between Food and Rispond 1 Tablet
Taking Rispond 1 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Rispond 1 Tablet
Taking Rispond 1 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Risperdal® (risperidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 441-442
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1101-1103